Both in R&D — Physical & Biological Sciences
bioAffinity Technologies vs NRC Health
Over the past year BIAF returned −92.1% and NRC returned +76.8%; their daily moves had a correlation of 0.06.
BIAF −92.1% NRC +76.8%Growth of $1, one year, split-adjusted
| Metric | BIAF | NRC |
|---|---|---|
| Price | $2.95 | $23.79 |
| Market cap | $1.8M | $504.8M |
| Today | −2.81% | +1.26% |
| 1 month | −52.1% | +11.6% |
| 6 months | −91.0% | +36.6% |
| Year to date | −83.4% | +26.7% |
| 1 year | −92.1% | +76.8% |
| Revenue growth (YoY) | +19.0% | +4.0% |
| Gross margin | 100.0% | 61.7% |
| Net margin | −222.8% | −9.3% |
| P/E (TTM) | — | 90.9× |
| Price / sales | 0.3× | 3.6× |
| Net cash | $1.8M | -$86.7M |
| Dividend yield | — | 2.69% |
| Volatility (60d) | 825.7% | 45.5% |
| Short % of float | 11.4% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).